Medicine and Dentistry
Adenocarcinoma
6%
Aldehyde Dehydrogenase
5%
Angiogenesis
6%
Antiangiogenic Therapy
11%
Atrial Fibrillation
5%
Brain Infarction
11%
Cancer Growth
6%
Caveolin 1
5%
Cholangiocarcinoma
11%
Clear Cell Renal Cell Carcinoma
6%
Computer Assisted Tomography
6%
Drug Resistance
7%
Endothelial Cell
58%
Esophageal Squamous Cell Carcinoma
8%
Fluorodeoxyglucose
7%
Gastrectomy
5%
Immunohistochemistry
6%
Immunoreactivity
6%
In Vitro
7%
Lobectomy
31%
Lung Adenocarcinoma
6%
Lung Cancer
30%
Lung Lobectomy
6%
Lymph Node Metastasis
9%
Malignant Neoplasm
7%
Metastatic Carcinoma
17%
Multidrug Resistance Protein 1
5%
Neoplasm
80%
Non Small Cell Lung Cancer
18%
Oral Bacteria
5%
Overall Survival
6%
Pleura Mesothelioma
13%
Pneumonectomy
29%
Positron Emission Tomography
10%
Prognostic Factor
16%
Pulmonary Sequestration
8%
Pulmonary Vein
13%
Squamous Cell Carcinoma
9%
Standardized Uptake Value
7%
Surgery
34%
Surgical Anastomosis
7%
Thrombosis
12%
Tumor Antigen
5%
Tumor Cell
10%
Tumor Microenvironment
10%
Tumor Progression
12%
Vascular Tissue Neoplasm
13%
Vasculotropin
6%
Video-Assisted Thoracoscopic Surgery
21%
Visceral Pleura
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antiangiogenic
7%
Antiangiogenic Therapy
12%
Biglycan
5%
Bile Duct Carcinoma
5%
Cancer Growth
6%
Caveolin 1
5%
Drug Resistance
12%
Lung Adenocarcinoma
5%
Lung Cancer
14%
Malignant Neoplasm
24%
Metastasis
13%
Mouse
6%
Multidrug Resistance Protein 1
5%
Neoplasm
100%
Neuropilin
5%
Pleura Mesothelioma
7%
Prostate Cancer
5%
Recurrent Disease
5%
Renal Cell Carcinoma
6%
Streptococcus mutans
5%
Tumor Growth
8%
Tumor Microenvironment
10%
Vascular Tumor
16%
Vasculotropin
9%
Keyphrases
Angiogenesis
7%
Biglycan
8%
Biliary Tract Carcinoma
5%
Caveolin-1 (Cav-1)
5%
Cerebral Infarction
8%
CXCR7
5%
Drug Resistance
8%
Esophageal Squamous Cell Carcinoma
8%
Hypoxia-inducible factor-1α (HIF-1α)
5%
Japan
5%
Left Upper Lobectomy
9%
Lobectomy
6%
Lung Cancer
10%
Lymph Node Metastasis
5%
Metastatic Stage
5%
Multifocal Micronodular Pneumocyte Hyperplasia
5%
Non-small Cell Lung Cancer (NSCLC)
5%
Overexpression
8%
Pathological Stage
5%
Prognostic Factors
9%
Pulmonary Resection
11%
Pulmonary Vein Stump
5%
RCAS1
5%
Risk Factors
11%
Squamous Cell Carcinoma (SqCC)
8%
Tumor
9%
Tumor Blood Vessels
9%
Tumor Endothelial Cells
26%
Tumor Microenvironment
6%
Video-assisted Thoracoscopic Surgery
8%
